In TCGA data set, the gene expression of BECN1, ATG16L1 or SQSTM1 were markedly lower in triple-negative breast cancers (n=82) compared with other subtypes (n=391) (Figure 7b). This evidence concerns the gene BECN1 and triple-negative breast carcinoma.